Matthew A. Windsor

547 total citations
9 papers, 466 citations indexed

About

Matthew A. Windsor is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Matthew A. Windsor has authored 9 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Matthew A. Windsor's work include Chemical Synthesis and Analysis (4 papers), Click Chemistry and Applications (4 papers) and Retinal and Optic Conditions (2 papers). Matthew A. Windsor is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Click Chemistry and Applications (4 papers) and Retinal and Optic Conditions (2 papers). Matthew A. Windsor collaborates with scholars based in United States, Switzerland and Canada. Matthew A. Windsor's co-authors include Samuel H. Gellman, Melissa Boersma, W. Seth Horne, Donald Hilvert, William C. K. Pomerantz, Manuel M. Müller, Philip J. Rosenfeld, David Huang, Kevin D. Frick and Eric A. Swanson and has published in prestigious journals such as Angewandte Chemie International Edition, Biochemistry and American Journal of Ophthalmology.

In The Last Decade

Matthew A. Windsor

9 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew A. Windsor United States 9 344 204 78 56 50 9 466
Natalia de la Figuera Spain 12 299 0.9× 237 1.2× 18 0.2× 15 0.3× 4 0.1× 23 419
J.A. Crapster United States 8 453 1.3× 228 1.1× 67 0.9× 35 0.6× 10 523
Michael P. Nova United States 8 341 1.0× 169 0.8× 5 0.1× 85 1.5× 57 1.1× 14 437
Alejandra Moure Spain 11 231 0.7× 141 0.7× 45 0.6× 7 0.1× 3 0.1× 16 350
Lars Linderoth Denmark 11 330 1.0× 84 0.4× 143 1.8× 28 0.5× 14 457
Ted J. Gauthier United States 12 269 0.8× 124 0.6× 50 0.6× 44 0.8× 23 406
Gianine Figliozzi United States 6 491 1.4× 228 1.1× 34 0.4× 146 2.6× 12 575
Brunello Nardone United Kingdom 8 384 1.1× 228 1.1× 19 0.2× 25 0.4× 12 440
Marta Paradís‐Bas Spain 9 361 1.0× 228 1.1× 40 0.5× 33 0.6× 12 444
Sangram S. Kale India 12 345 1.0× 224 1.1× 43 0.6× 71 1.3× 1 0.0× 15 408

Countries citing papers authored by Matthew A. Windsor

Since Specialization
Citations

This map shows the geographic impact of Matthew A. Windsor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Windsor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Windsor more than expected).

Fields of papers citing papers by Matthew A. Windsor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Windsor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Windsor. The network helps show where Matthew A. Windsor may publish in the future.

Co-authorship network of co-authors of Matthew A. Windsor

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Windsor. A scholar is included among the top collaborators of Matthew A. Windsor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Windsor. Matthew A. Windsor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Rosenfeld, Philip J., Matthew A. Windsor, William J. Feuer, et al.. (2018). Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative Age-related Macular Degeneration. American Journal of Ophthalmology. 191. 135–139. 29 indexed citations
2.
Windsor, Matthew A., et al.. (2017). Estimating Public and Patient Savings From Basic Research—A Study of Optical Coherence Tomography in Managing Antiangiogenic Therapy. American Journal of Ophthalmology. 185. 115–122. 30 indexed citations
3.
Windsor, Matthew A., et al.. (2013). Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib. Bioorganic & Medicinal Chemistry Letters. 23(21). 5860–5864. 14 indexed citations
4.
Windsor, Matthew A., Daniel Hermanson, Philip J. Kingsley, et al.. (2012). Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen Probes. ACS Medicinal Chemistry Letters. 3(9). 759–763. 33 indexed citations
5.
Lü, Duo, Matthew A. Windsor, Samuel H. Gellman, & James L. Keck. (2009). Peptide Inhibitors Identify Roles for SSB C-Terminal Residues in SSB/Exonuclease I Complex Formation. Biochemistry. 48(29). 6764–6771. 28 indexed citations
6.
Horne, W. Seth, Melissa Boersma, Matthew A. Windsor, & Samuel H. Gellman. (2008). Sequence‐Based Design of α/β‐Peptide Foldamers That Mimic BH3 Domains. Angewandte Chemie. 120(15). 2895–2898. 23 indexed citations
7.
Horne, W. Seth, Melissa Boersma, Matthew A. Windsor, & Samuel H. Gellman. (2008). Sequence‐Based Design of α/β‐Peptide Foldamers That Mimic BH3 Domains. Angewandte Chemie International Edition. 47(15). 2853–2856. 130 indexed citations
8.
Müller, Manuel M., Matthew A. Windsor, William C. K. Pomerantz, Samuel H. Gellman, & Donald Hilvert. (2008). A Rationally Designed Aldolase Foldamer. Angewandte Chemie International Edition. 48(5). 922–925. 144 indexed citations
9.
Müller, Manuel M., Matthew A. Windsor, William C. K. Pomerantz, Samuel H. Gellman, & Donald Hilvert. (2008). A Rationally Designed Aldolase Foldamer. Angewandte Chemie. 121(5). 940–943. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026